Table of Contents Author Guidelines Submit a Manuscript
Journal of Osteoporosis
Volume 2012, Article ID 907214, 2 pages

Secondary Osteoporosis: Endocrine and Metabolic Causes of Bone Mass Deterioration

1Department of Hypertension and Internal Medicine, Pomeranian Medical University, Szczecin, Poland
2Wayne State University, St. John River District Hospital, MI 48054, USA
3Klinik und Poliklinik für Radiologie und Nuklearmedizin, Zentrum für Muskel- und Knochenforschung, Berlin, Germany
4Charles University, Prague, Czech Republic
5INSERM Unit 821, Lyon, France

Received 29 December 2011; Accepted 29 December 2011

Copyright © 2012 Tomasz Miazgowski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Romagnoli, R. Del Fiacco, S. Russo et al., “Secondary osteoporosis in men and women: clinical challenge of an unresolved issue,” Journal of Rheumatology, vol. 38, no. 8, pp. 1671–1679, 2011. View at Publisher · View at Google Scholar · View at PubMed
  2. S. P. G. Bours, T. A. C. M. van Geel, P. P. M. M. Geusens et al., “Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 5, pp. 1360–1367, 2011. View at Publisher · View at Google Scholar · View at PubMed